Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

The Characterization of Metabolic Profile and Substrates Dependencies of Richter's Syndrome Cells Open for Translational Opportunities

Matilde Micillo, Lorenzo Brandimarte, Giulia Omezzolli, Nadia Bertola, Francesco Edoardo Vallone, Andrea Iannello, Chiara Lavarello, Nicole Grinovero, Giulio Ferrero, Kevin Mellert, Peter Moller, Nicoletta Vitale, Silvia Bruno, Richard R. Furman, John N. Allan, Andrea Petretto, Silvia Deaglio, Silvia Ravera, Tiziana Vaisitti

Blood (2023) 142 (Supplement 1): 6115.

https://doi.org/10.1182/blood-2023-179164

Published: 2023

Journal Articles

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Blood (2021) 138 (11): 992–996.

https://doi.org/10.1182/blood.2021012479

Published: 2021

Includes: Supplemental data

Journal Articles

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Blood (2020) 135 (3): 181–190.

https://doi.org/10.1182/blood.2019000560

Published: 2020

Includes: Supplemental data

Journal Articles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Blood (2019) 134 (Supplement_1): 4202.

https://doi.org/10.1182/blood-2019-126164

Published: 2019

Journal Articles

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Blood (2018) 132 (26): 2744–2753.

https://doi.org/10.1182/blood-2018-03-836932

Published: 2018

Includes: Supplemental data

Journal Articles

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Blood (2018) 132 (Supplement 1): 580.

https://doi.org/10.1182/blood-2018-99-111255

Published: 2018

Journal Articles

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

Jorne Lionel Biccler, MSc, Marianne Tang Severinsen, MD PhD, Lene Sofie Granfeldt Oestgaard, MD PhD, Claus Werenberg Marcher, MD PhD, Peter Møller, MD, Claudia Schöllkopf, MD PhD, Lone Smidstrup Friis, MD PhD, Lasse Hjort Jakobsen, MSc, Tarec Christoffer El-Galaly, MD PhD, Jan M. Nørgaard, MD PhD

Blood (2017) 130 (Supplement 1): 2595.

https://doi.org/10.1182/blood.V130.Suppl_1.2595.2595

Published: 2017

Journal Articles

A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells

Malena Zahn, Ralf Marienfeld, Ingo Melzner, Janine Heinrich, Benjamin Renner, Silke Wegener, Anna Mießner, Thomas F. E. Barth, Karola Dorsch, Silke Brüderlein, Peter Möller

Blood (2017) 129 (11): 1480–1490.

https://doi.org/10.1182/blood-2016-06-720516

Published: 2017

Includes: Supplemental data

Journal Articles

B-cell–specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice

Blood (2016) 127 (22): 2732–2741.

https://doi.org/10.1182/blood-2015-11-684183

Published: 2016

Includes: Supplemental data

Journal Articles

No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study

Lukas Frans Ocias, Dennis Lund Hansen, Thomas Kielsgaard Kristensen, Karin de Stricker, Daniel El Fassi, MD PhD, Jesper Stentoft, Jørn Starklint, Mikael Frederiksen, Marianne Tang Severinsen, Ole Weis Bjerrum, MD DMSc, Peter Møller, Torben Mourits-Andersen, MD, Ulrik Malthe Overgaard, Hans Carl Hasselbalch, MD Professor, DMSc, Klaus Bendtzen, Thomas Stauffer Larsen, MD PhD

Blood (2015) 126 (23): 5177.

https://doi.org/10.1182/blood.V126.23.5177.5177

Published: 2015

Journal Articles

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

Blood (2014) 124 (20): 3118–3129.

https://doi.org/10.1182/blood-2014-07-590570

Published: 2014

Includes: Supplemental data

Journal Articles

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Anja Mottok, Roshanak Bob, Karoline Koch, Heinz-Wolfram Bernd, Sergio Cogliatti, Michael Hummel, Alfred C. Feller, German Ott, Peter Möller, Andreas Rosenwald, Harald Stein, Martin-Leo Hansmann, Andreas Engert, Wolfram Klapper

Blood (2013) 122 (26): 4246–4252.

https://doi.org/10.1182/blood-2013-07-515825

Published: 2013

Includes: Supplemental data

Journal Articles

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

Blood (2013) 122 (21): 4262.

https://doi.org/10.1182/blood.V122.21.4262.4262

Published: 2013

Journal Articles

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Blood (2013) 121 (12): 2253–2263.

https://doi.org/10.1182/blood-2012-06-435842

Published: 2013

Journal Articles

Telomere length in mantle cell lymphoma

Billy Michael Chelliah Jebaraj, Dirk Kienle, André Lechel, Daniel Mertens, Maria Heuberger, German Ott, Andreas Rosenwald, Thomas F. E. Barth, Peter Möller, Thorsten Zenz, Hartmut Döhner, Stephan Stilgenbauer

Blood (2013) 121 (7): 1184–1187.

https://doi.org/10.1182/blood-2012-08-452649

Published: 2013

Includes: Supplemental data

Journal Articles

Antibiotics as first-line therapy for Hp -associated gastric large B-cell lymphoma? Probably yes.

Peter Möller, Andreas Viardot

Blood (2012) 119 (21): 4818–4819.

https://doi.org/10.1182/blood-2012-03-417345

Published: 2012

Journal Articles

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma

Linka Xie, Alexey Ushmorov, Frank Leithäuser, Hanfeng Guan, Christian Steidl, Johanna Färbinger, Christin Pelzer, Marion J. Vogel, Harald J. Maier, Randy D. Gascoyne, Peter Möller, Thomas Wirth

Blood (2012) 119 (15): 3503–3511.

https://doi.org/10.1182/blood-2011-09-381905

Published: 2012

Includes: Supplemental data

Journal Articles

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

Blood (2010) 116 (23): 4916–4925.

https://doi.org/10.1182/blood-2010-03-276766

Published: 2010

Journal Articles

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

Hanfeng Guan, Linka Xie, Frank Leithäuser, Lucia Flossbach, Peter Möller, Thomas Wirth, Alexey Ushmorov

Blood (2010) 116 (9): 1469–1478.

https://doi.org/10.1182/blood-2009-12-256446

Published: 2010

Includes: Supplemental data

Journal Articles

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Chuanhui Xu, Anke Van Den Berg, PhD, Arjan Diepstra, Miao Wang, Debora Jong, Hans JTWM Vos, Peter Moller, MD, Sibrand Poppema, MD, PhD, Lydia Visser

Blood (2009) 114 (22): 1551.

https://doi.org/10.1182/blood.V114.22.1551.1551

Published: 2009

NARROW

The Characterization of Metabolic Profile and Substrates Dependencies of Richter's Syndrome Cells Open for Translational Opportunities

The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia

Localized- and advanced-stage follicular lymphomas differ in their gene expression profiles

Genomic Profiling of a Phase III Clinical Trial of Interferon Versus Hydroxyurea in MPN Patients Reveals Mutation-Specific and Treatment-Specific Patterns of Response

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Long-Term Efficacy and Safety of Recombinant Interferon Alpha-2 Vs. Hydroxyurea in Polycythemia Vera: Preliminary Results from the Three-Year Analysis of the Daliah Trial - a Randomized Controlled Phase III Clinical Trial

Promyelocytic Leukemia Patients Surviving the Critical Initial Phase Have Survival Equivalent to That of the Calendar Year-, Sex-, and Age-Matched General Population

A novel PTPN1 splice variant upregulates JAK/STAT activity in classical Hodgkin lymphoma cells

B-cell–specific conditional expression of Myd88 p.L252P leads to the development of diffuse large B-cell lymphoma in mice

No Development of Neutralizing Antibodies Against Recombinant Interferon-Alpha in Ph-Negative Myeloproliferative Neoplasms - a Prospective Study

FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Telomere length in mantle cell lymphoma

Antibiotics as first-line therapy for Hp -associated gastric large B-cell lymphoma? Probably yes.

FOXO1 is a tumor suppressor in classical Hodgkin lymphoma

Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL

KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma

The HGF/c-Met Signaling Pathway in Hodgkin Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only